概括
在大多数患者中,口服阿米奥达龙有效治疗了心室性心力衰竭,表现出很好的长期耐受性. 虽然疗效需要时间,但阿米奥达龙在心律失常管理方面表现出长时间的作用和良好的安全性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 持续的,反复的,有症状的腹腔动脉短心症带来了重大的临床挑战.
- 有效的长期管理策略对于心室动脉冲动是至关重要的.
研究的目的:
- 为了评估口服阿米奥达龙在患有复发性心室动脉冲动症的患者中的疗效和安全性.
- 评估阿米奥达龙治疗的长期结果和耐受性.
主要方法:
- 二十三名患有症状的腹腔心动减速症的患者接受了口服阿米奥达龙.
- 剂量最初在每天600-2000毫克之间,维持剂量为每天200-1200毫克.
- 在长时间的随访期间,对患者的结果,复发和不良事件进行了监测.
主要成果:
- 阿米奥达龙在87%的患者 (20/23) 中具有高度有效性.
- 15名患者 (65%) 在平均21.5个月的随访期间没有出现复发.
- 观察到优异的短期和长期耐受性,没有因不良反应而停止治疗.
结论:
- 口服阿米奥达龙是一种高度有效且耐受性很好的治疗持续性,复发性,症状性心室低心率.
- 尽管作用的开始延迟,阿米奥达龙提供了长期的抗心律失常效益和有利的安全性.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias VII: Nursing Management of Dysrhythmias
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...


